Stock listing
INMB Stock Price, News, Filings & Events — Inmune Bio Inc.
Selected listing: INMB · NASDAQ · USD · US
INMB:NASDAQ is the primary listing for Inmune Bio Inc., a public company with a market capitalization of approximately $43.1 million. The company is dedicated to developing innovative therapies that leverage the body's immune system to treat various diseases. Recent news and filings may provide insights into their ongoing projects and advancements in the field. Investors can stay informed about upcoming events and market context related to Inmune Bio's progress and strategic direction.
- Ticker
- INMB:NASDAQ
- Asset type
- Stock
- Market cap
- $43.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Inmune Bio Inc. INMB:NASDAQ stock context
INMB:NASDAQ is the primary listing for Inmune Bio Inc., a public company with a market capitalization of approximately $43.1 million. The company is dedicated to developing innovative therapies that leverage the body's immune system to treat various diseases. Recent news and filings may provide insights into their ongoing projects and advancements in the field. Investors can stay informed about upcoming events and market context related to Inmune Bio's progress and strategic direction.
Research Inmune Bio Inc.
Inmune Bio Inc. investor report
Review AI stock analysis and investor report context for INMB:NASDAQ.
Inmune Bio Inc. company profile
View the public company page for Inmune Bio Inc. on 6ix.
Inmune Bio Inc. news
Read company news and market updates connected to Inmune Bio Inc..
Inmune Bio Inc. investor events
Find investor webinars, events, and replay context for Inmune Bio Inc..
Alternate listings
INMB:BOATS
US · USD
Alternate listing for Inmune Bio Inc.; the primary context on this page is INMB:NASDAQ.
A2PCBU:LS
DE · EUR
Alternate listing for Inmune Bio Inc.; the primary context on this page is INMB:NASDAQ.
0Y2:TRADEGATE
DE · EUR
Alternate listing for Inmune Bio Inc.; the primary context on this page is INMB:NASDAQ.